Faeth Therapeutics, Inc.

NASDAQ:FTH

Biotechnology

Healthcare
$8.72 +5.01%

+$1.43 today

Market cap
$224.79M
Beta
-0.31
P/E (TTM)
-0.2
EPS (TTM)
-$34.65
52W Low $7.21High $37.90

Volume 0.33M

Average 0.12M

Balance Sheet

Inspect the capital base behind the business.

Assets

$22.90M

FY 2025 · Annual

-49.5% YoY

Liabilities

$4.31M

FY 2025 · Annual

-38.2% YoY

Equity

$18.59M

FY 2025 · Annual

-51.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents7.16M17.8M13.01M9.99M8.67M
Short-term Investments140.46M89.32M52.75M31.34M12.52M
Net Receivables00000
Inventory00000
Other Current Assets374K344K325K120K92K
Total Current Assets148.54M108.59M67.25M41.93M21.51M
Property, Plant & Equipment (Net)4.64M9.72M7.04M3.38M1.38M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets39K63K86K48K18K
Total Non-current Assets4.68M9.79M7.12M3.43M1.4M
Total Assets153.23M118.38M74.37M45.36M22.9M
Account Payables2.46M4.47M1.69M244K689K
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities0002.01M1.4M
Total Current Liabilities4.89M9.07M5.64M5.45M4.25M
Long-term Debt000059K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities149K067K00
Total Non-current Liabilities1.82M5.9M3.84M1.53M59K
Total Liabilities6.71M14.97M9.48M6.98M4.31M
Common Stock3K3K3K3K0
Retained Earnings(149.21M)(197.79M)(231.9M)(262.05M)(283.14M)
Accumulated OCI(333K)(1M)(209K)(13K)1K
Other Stockholders Equity(0)0000
Minority Interest00000
Total Equity146.51M103.41M64.9M38.39M18.59M
Total Debt2.35M8.03M6.21M3.85M1.51M
Net Debt(4.81M)(9.76M)(6.8M)(6.15M)(7.16M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$26.9M
Short-term Investments$159.5M
Other Current$2.2M
Total Current Assets$188.7M
PP&E (Net)$568.0K
Other Non-current$80.0K
Total Non-current Assets$648.0K
Total Assets$189.3M

Analysis

Selected assets total $189.3M for Latest. The largest visible component is Short-term Investments at $159.5M, about 84.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 3, 2026
S-8S-8 filingNov 3, 2026

How much cash does FTH have?

Faeth Therapeutics, Inc. (FTH) reported $8.67M in cash and equivalents in fiscal 2025.

How much debt does FTH carry?

Faeth Therapeutics, Inc. (FTH) reported $1.51M of total debt, with net debt of -$7.16M.